{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T12:00:48Z","timestamp":1783857648967,"version":"3.55.0"},"reference-count":39,"publisher":"e-Century Publishing Corporation","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/qxzb5406","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T06:15:14Z","timestamp":1753942514000},"page":"5120-5128","source":"Crossref","is-referenced-by-count":1,"title":["Predicting hepatitis C infection via machine learning"],"prefix":"10.62347","volume":"17","author":[{"given":"Yueyue","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.3390\/jcm13144012","article-title":"Hepatitis C virus (HCV) infection: pathogenesis, oral manifestations, and the role of direct-acting antiviral therapy: a narrative review","volume":"13","author":"Di Stasio","year":"2024","unstructured":"Di Stasio D, Guida A, Romano A, Petruzzi M, Marrone A, Fiori F and Lucchese A. Hepatitis C virus (HCV) infection: pathogenesis, oral manifestations, and the role of direct-acting antiviral therapy: a narrative review. J Clin Med 2024; 13: 4012.","journal-title":"J Clin Med"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/1348-0421.13023","article-title":"Hepatitis C virus, insulin resistance, and diabetes: a review","volume":"66","author":"Alzahrani","year":"2022","unstructured":"Alzahrani N. Hepatitis C virus, insulin resistance, and diabetes: a review. Microbiol Immunol 2022; 66: 453-459.","journal-title":"Microbiol Immunol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/v17010021","article-title":"Impact of age and sex on viral load in hepatitis C virus infection","volume":"17","author":"Magri","year":"2024","unstructured":"Magri A, Manfredi GF, Smirne C, Pigni S, Burlone ME, Bellan M, Vercellino N, Minisini R and Pirisi M. Impact of age and sex on viral load in hepatitis C virus infection. Viruses 2024; 17: 21.","journal-title":"Viruses"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.32604\/biocell.2018.07009","article-title":"Associations between CD133, CK19 and G2\/M in cirrhotic HCV (genotype-4) patients with or without accompanying tumor","volume":"42","author":"El-Emshaty","year":"2018","unstructured":"El-Emshaty HM, Saad EA, Gouida MS and Elshahawy ZR. Associations between CD133, CK19 and G2\/M in cirrhotic HCV (genotype-4) patients with or without accompanying tumor. Biocell 2018; 42: 55-60.","journal-title":"Biocell"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Burki T. WHO’s 2024 global hepatitis report. Lancet Infect Dis 2024; 24: e362-e363.","DOI":"10.1016\/S1473-3099(24)00307-4"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"101483","DOI":"10.1016\/j.gendis.2024.101483","article-title":"Deciphering the roles of neddylation modification in hepatocellular carcinoma: molecular mechanisms and targeted therapeutics","volume":"12","author":"Wu","year":"2024","unstructured":"Wu W, Wang X, Ma R, Huang S, Li H and Lyu X. Deciphering the roles of neddylation modification in hepatocellular carcinoma: molecular mechanisms and targeted therapeutics. Genes Dis 2024; 12: 101483.","journal-title":"Genes Dis"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Adugna A. Therapeutic strategies and promising vaccine for hepatitis C virus infection. Immun Inflamm Dis 2023; 11: e977.","DOI":"10.1002\/iid3.977"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.gendis.2023.02.050","article-title":"WNT\/β-catenin signaling in hepatocellular carcinoma: the aberrant activation, pathogenic roles, and therapeutic opportunities","volume":"11","author":"Gajos-Michniewicz","year":"2023","unstructured":"Gajos-Michniewicz A and Czyz M. WNT\/β-catenin signaling in hepatocellular carcinoma: the aberrant activation, pathogenic roles, and therapeutic opportunities. Genes Dis 2023; 11: 727-746.","journal-title":"Genes Dis"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Quan W, Bello KE, Shueb Shomiad RH and Mustaffa N. Circular RNAs in hepatitis B virus-induced hepatocellular carcinoma: a comprehensive review and recent advances. Genes Dis 2025; 101605.","DOI":"10.1016\/j.gendis.2025.101605"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Westbrook RH and Dusheiko G. Natural history of hepatitis C. J Hepatol 2014; 61: S58-68.","DOI":"10.1016\/j.jhep.2014.07.012"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3350\/cmh.2021.0193","article-title":"Cost-effectiveness of chronic hepatitis C screening and treatment","volume":"28","author":"Lee","year":"2022","unstructured":"Lee HW, Lee H, Kim BK, Chang Y, Jang JY and Kim DY. Cost-effectiveness of chronic hepatitis C screening and treatment. Clin Mol Hepatol 2022; 28: 164-173.","journal-title":"Clin Mol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.32604\/biocell.2022.023568","article-title":"A double-edged sword: the HBV-induced non-coding RNAs alterations in hepatocellular carcinoma","volume":"47","author":"Liu","year":"2023","unstructured":"Liu T and Diao H. A double-edged sword: the HBV-induced non-coding RNAs alterations in hepatocellular carcinoma. Biocell 2023; 47: 27-32.","journal-title":"Biocell"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Butt ZA, Wong S, Rossi C, Binka M, Wong J, Yu A, Darvishian M, Alvarez M, Chapinal N, McKee G, Gilbert M, Tyndall MW, Krajden M and Janjua NZ. Concurrent hepatitis C and B virus and human immunodeficiency virus infections are associated with higher mortality risk illustrating the impact of syndemics on health outcomes. Open Forum Infect Dis 2020; 7: ofaa347.","DOI":"10.1093\/ofid\/ofaa347"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.3748\/wjg.v28.i30.4182","article-title":"Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: a prospective cohort study","volume":"28","author":"Choi","year":"2022","unstructured":"Choi GH, Jang ES, Kim YS, Lee YJ, Kim IH, Cho SB, Lee HC, Jang JW, Ki M, Choi HY, Baik D and Jeong SH. Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: a prospective cohort study. World J Gastroenterol 2022; 28: 4182-4200.","journal-title":"World J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12876-021-01770-0","article-title":"Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study","volume":"21","author":"Fujiyama","year":"2021","unstructured":"Fujiyama S, Akuta N, Sezaki H, Kobayashi M, Kawamura Y, Hosaka T, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Arase Y, Ikeda K and Kumada H. Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study. BMC Gastroenterol 2021; 21: 189.","journal-title":"BMC Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"678546","DOI":"10.3389\/fphar.2021.678546","article-title":"Impact of DAA treatment on cardiovascular disease risk in chronic HCV infection: an update","volume":"12","author":"Roguljic","year":"2021","unstructured":"Roguljic H, Nincevic V, Bojanic K, Kuna L, Smolic R, Vcev A, Primorac D, Vceva A, Wu GY and Smolic M. Impact of DAA treatment on cardiovascular disease risk in chronic HCV infection: an update. Front Pharmacol 2021; 12: 678546.","journal-title":"Front Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.3748\/wjg.v22.i18.4547","article-title":"Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence","volume":"22","author":"AT","year":"2016","unstructured":"Song AT, Sobesky R, Vinaixa C, Dumortier J, Radenne S, Durand F, Calmus Y, Rousseau G, Latournerie M, Feray C, Delvart V, Roche B, Haim-Boukobza S, Roque-Afonso AM, Castaing D, Abdala E, D’Albuquerque LA, Duclos-Vallée JC, Berenguer M and Samuel D. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence. World J Gastroenterol 2016; 22: 4547-4558.","journal-title":"World J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Gobran ST, Pagliuzza A, Khedr O, Fert A, Chomont N, Bruneau J, Klein MB, Ancuta P and Shoukry NH. DAA-mediated HCV cure reduces HIV DNA levels in HCV\/HIV coinfected people. J Virol 2023; 97: e0110523.","DOI":"10.1128\/jvi.01105-23"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.32604\/biocell.2022.022257","article-title":"Long term immunological perturbations post DAA therapy in chronic HCV\/HIV co-infected patients","volume":"46","author":"Moretti","year":"2022","unstructured":"Moretti S, Mancini F and Borsetti A. Long term immunological perturbations post DAA therapy in chronic HCV\/HIV co-infected patients. Biocell 2022; 46: 2695-2699.","journal-title":"Biocell"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/apt.17198","article-title":"Meta-analysis: diagnostic accuracy of hepatitis C core antigen detection during therapy with direct-acting antivirals","volume":"56","author":"Sep&#xFA","year":"2022","unstructured":"Sepúlveda-Crespo D, Treviño-Nakoura A, Bellon JM, Ardizone Jiménez B, Jiménez-Sousa MA, Fernández-Rodríguez A, Martínez I and Resino S. Meta-analysis: diagnostic accuracy of hepatitis C core antigen detection during therapy with direct-acting antivirals. Aliment Pharmacol Ther 2022; 56: 1224-1234.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Hansoongnern P, Pratedrat P, Nilyanimit P, Wasitthankasem R, Posuwan N, Wanlapakorn N, Kodchakorn K, Kongtawelert P, Pimsing N and Poovorawan Y. An amino acid substitution in HCV core antigen limits its use as a reliable measure of HCV infection compared with HCV RNA. PLoS One 2023; 18: e0287694.","DOI":"10.1371\/journal.pone.0287694"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Wang Y, Jie W, Ling J and Yuanshuai H. HCV core antigen plays an important role in the fight against HCV as an alternative to HCV-RNA detection. J Clin Lab Anal 2021; 35: e23755.","DOI":"10.1002\/jcla.23755"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3390\/pathogens13040331","article-title":"Biomarkers in detection of hepatitis C virus infection","volume":"13","author":"Woo","year":"2024","unstructured":"Woo J and Choi Y. Biomarkers in detection of hepatitis C virus infection. Pathogens 2024; 13: 331.","journal-title":"Pathogens"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13036-024-00443-2","article-title":"Current advances in Hepatitis C diagnostics","volume":"18","author":"AS","year":"2024","unstructured":"Baber AS, Suganthan B and Ramasamy RP. Current advances in Hepatitis C diagnostics. J Biol Eng 2024; 18: 48.","journal-title":"J Biol Eng"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.32604\/biocell.2023.027373","article-title":"Genetic algorithmoptimized backpropagation neural network establishes a diagnostic prediction model for diabetic nephropathy: combined machine learning and experimental validation in mice","volume":"47","author":"Liang","year":"2023","unstructured":"Liang WEI, Zhang Z, Yang K, Hu H, Luo Q, Yang A, Chang LI and Zeng Y. Genetic algorithmoptimized backpropagation neural network establishes a diagnostic prediction model for diabetic nephropathy: combined machine learning and experimental validation in mice. Biocell 2023; 47: 1253-1263.","journal-title":"Biocell"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Long X, Chen Y, Yin M and Liu W. Improving HCV diagnosis following a false-negative anti-HCV result. Clin Chem Lab Med 2024; 62: e229-e231.","DOI":"10.1515\/cclm-2024-0161"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/labmed\/lmaa074","article-title":"Evaluation of HCV RNA by PCR and signal-to-cutoff ratios of HCV antibody assays for diagnosis of HCV infection","volume":"52","author":"Kim","year":"2021","unstructured":"Kim MH, Kang SY, Lee WI and Lee MY. Evaluation of HCV RNA by PCR and signal-to-cutoff ratios of HCV antibody assays for diagnosis of HCV infection. Lab Med 2021; 52: 240-244.","journal-title":"Lab Med"},{"key":"ref27","unstructured":"Xu B, Chen B, Ma ZH, Ren YN, Ma JQ, Pei LJ and Xing WW. Application of anti-HCV and HCV RNA detection in intravenous drug users. Zhonghua Gan Zang Bing Za Zhi 2021; 29: 415-420."},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Curtis KA, Rudolph DL, Pan Y, Delaney K, Anastos K, DeHovitz J, Kassaye SG, Hanson CV, French AL, Golub E, Adimora AA, Ofotokun I, Bolivar H, Kempf MC, Peters PJ and Switzer WM. Evaluation of the Abbott ARCHITECT HIV Ag\/Ab combo assay for determining recent HIV-1 infection. PLoS One 2021; 16: e0242641.","DOI":"10.1371\/journal.pone.0242641"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Liu HY, Lin YH, Lin PJ, Tsai PC, Liu SF, Huang YC, Tsai JJ, Huang CI, Yeh ML, Liang PC, Lin ZY, Dai CY, Huang JF, Chuang WL, Huang CF and Yu ML. Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection. PLoS One 2021; 16: e0254028.","DOI":"10.1371\/journal.pone.0254028"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41420-023-01749-8","article-title":"Programmed cell death in hepatic fibrosis: current and perspectives","volume":"9","author":"JL","year":"2023","unstructured":"Lu JL, Yu CX and Song LJ. Programmed cell death in hepatic fibrosis: current and perspectives. Cell Death Discov 2023; 9: 449.","journal-title":"Cell Death Discov"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"101596","DOI":"10.1016\/j.clinre.2020.101596","article-title":"Epidemiology of hepatitis C virus infection","volume":"45","author":"Roudot-Thoraval","year":"2021","unstructured":"Roudot-Thoraval F. Epidemiology of hepatitis C virus infection. Clin Res Hepatol Gastroenterol 2021; 45: 101596.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.gendis.2022.08.013","article-title":"Interplays of liver fibrosis-associated microRNAs: molecular mechanisms and implications in diagnosis and therapy","volume":"10","author":"Li","year":"2023","unstructured":"Li H, Liu T, Yang Y, Cho WC, Flynn RJ, Harandi MF, Song H, Luo X and Zheng Y. Interplays of liver fibrosis-associated microRNAs: molecular mechanisms and implications in diagnosis and therapy. Genes Dis 2023; 10: 1457-1469.","journal-title":"Genes Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.32604\/biocell.2025.059908","article-title":"Mitochondrial oxidative stress-associated mechanisms in the development of metabolic dysfunction-associated steatotic liver disease","volume":"49","author":"Yang","year":"2025","unstructured":"Yang J, Zhang J, Zhang L and Yang Z. Mitochondrial oxidative stress-associated mechanisms in the development of metabolic dysfunction-associated steatotic liver disease. Biocell 2025; 49: 399-417.","journal-title":"Biocell"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/v16030371","article-title":"Effects of HCV clearance with direct-acting antivirals (DAAs) on liver stiffness, liver fibrosis stage and metabolic\/cellular parameters","volume":"16","author":"Ferreira","year":"2024","unstructured":"Ferreira J, Bicho M and Serejo F. Effects of HCV clearance with direct-acting antivirals (DAAs) on liver stiffness, liver fibrosis stage and metabolic\/cellular parameters. Viruses 2024; 16: 371.","journal-title":"Viruses"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"114587","DOI":"10.1016\/j.biopha.2023.114587","article-title":"Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV\/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy","volume":"162","author":"Tarancon-Diez L","year":"2023","unstructured":"Tarancon-Diez L, Carrasco I, Jiménez de Ory S, Berzosa Sánchez A, Hernanz-Lobo A, Montero-Alonso M, Laguno M, Bernardino JI, López-Cortés L, Aldamiz-Echevarría T, Collado P, Bisbal O, Samperiz G, Gavilán C, Ríos MJ, Ibarra S, Navarro ML and Muñoz-Fernández M. Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV\/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy. Biomed Pharmacother 2023; 162: 114587.","journal-title":"Biomed Pharmacother"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"101327","DOI":"10.1016\/j.gendis.2024.101327","article-title":"YTHDF1 shapes immune-mediated hepatitis via regulating inflammatory cell recruitment and response","volume":"12","author":"Li","year":"2024","unstructured":"Li H, Yu K, Zhang X, Li J, Hu H, Deng X, Zeng S, Dong X, Zhao J and Zhang Y. YTHDF1 shapes immune-mediated hepatitis via regulating inflammatory cell recruitment and response. Genes Dis 2024; 12: 101327.","journal-title":"Genes Dis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.3390\/jcm13102939","article-title":"A machine learning-based mortality prediction model for patients with chronic hepatitis C infection: an exploratory study","volume":"13","author":"Al Alawi","year":"2024","unstructured":"Al Alawi AM, Al Shuaili HH, Al-Naamani K, Al Naamani Z and Al-Busafi SA. A machine learning-based mortality prediction model for patients with chronic hepatitis C infection: an exploratory study. J Clin Med 2024; 13: 2939.","journal-title":"J Clin Med"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Feld JJ. What is needed to move toward single-step diagnosis of current HCV infection? J Infect Dis 2024; 229: S316-S321.","DOI":"10.1093\/infdis\/jiad453"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/7\/ajtr0165347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:31Z","timestamp":1766022991000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/7\/ajtr0165347.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/qxzb5406","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}